CORPORATE Angelini Ventures Informazioni 70, Viale Amelia Roma Italia martina.palmese@angeliniventures.com - info@angeliniventures.com https://www.angeliniventures.com/ Struttura Numero di Executives: Numero di fondi: Numero di fondi art. 8 SFDR: Numero di fondi art. 9 SFDR: Totale capitale gestito: Numero di portfolio companies: Policy di investimento Investimento minimo: Investimento massimo: Preferenze geografiche: Focus di investimento: Preferenze di settore: Remarks Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and HealthTech. Angelini Ventures will invest €300 million across a global portfolio in Europe and North America, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies.To date, Angelini Ventures has invested around €135 million into 23 companies covering a range of therapeutic areas and modalities. Angelini Ventures’ BioTech portfolio includes Elkedonia, Therini Bio, Nuevocor, Neumirna, Cour Pharmaceuticals, Nouscom, Pretzel Therapeutics, Freya Biosciences and Adcytherix. The Company’s Digital Health portfolio includes Vantis Health, Avation, Cadence Neuroscience, Nobi, Noctrix and Serenis. CORPORATE Angelini Ventures Informazioni 70, Viale AmeliaRomaItalia martina.palmese@angeliniventures.com - info@angeliniventures.com https://www.angeliniventures.com/ Remarks Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and HealthTech. Angelini Ventures will invest €300 million across a global portfolio in Europe and North America, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies.To date, Angelini Ventures has invested around €135 million into 23 companies covering a range of therapeutic areas and modalities. Angelini Ventures’ BioTech portfolio includes Elkedonia, Therini Bio, Nuevocor, Neumirna, Cour Pharmaceuticals, Nouscom, Pretzel Therapeutics, Freya Biosciences and Adcytherix. The Company’s Digital Health portfolio includes Vantis Health, Avation, Cadence Neuroscience, Nobi, Noctrix and Serenis.